[Edaily Reporter KIM JI-WAN ] DREAMINSIGHT Co.,Ltd.(362990)is resuming its share buyback program to stabilize its stock price and enhance shareholder value. Following a 1 billion won purchase in June, the company is adding another 500 million won this time, bringing the total amount of the two buyback rounds to 1.5 billion won.
DREAMINSIGHT Co.,Ltd. announced in a regulatory filing on the 2nd that it will directly purchase common stock on the open market through Meritz Securities from November 3 to February 2 of next year. The planned acquisition volume is 455,373 shares, calculated based on the closing price of 1,098 won on October 30. The actual number of shares purchased will vary depending on the stock price, and the acquisition period may be shortened if the purchases are completed early.
Previously, after deciding to repurchase its own shares on June 25, the company purchased 817,197 common shares by September. It currently holds 1,221,159 shares of its own stock. If the company purchases the entire planned amount this time, its holdings will increase to 1,676,532 shares. Based on the separate financial statements as of the end of last year, the limit for the acquisition of treasury stock is approximately 30.5 billion won.
DREAMINSIGHT Co.,Ltd. stated, “This treasury stock acquisition is a decision aimed at stabilizing the stock price and enhancing shareholder value,” adding, “We will continue our efforts to strengthen our business competitiveness and enhance shareholder value.”
Kim Young-jin, a team leader in charge of HVAC technology development at SamsungElectronics, was awarded the Silver Tower Order of Industrial Service Merit in recognition of his contributions to reduc…
OSTEONIC Co., Ltd.(226400)reported cumulative sales of 39.8 billion won for the first three quarters of this year, driven by expanded overseas sales. Overseas sales slightly exceeded domestic sales in…
Plasmapp Co., Ltd.(405000)
Photo of the STERI 700 product. (Photo courtesy of Plasmapp Co., Ltd.)
Plasmapp Co., Ltd., a plasma meditech specialist, announced on the 16th that it has received appr…